| Hyperthermia Combined with Radiation and Androgen Therapy Provides ...
BSD Medical Corp. (AMEX:BSM) today announced that the International Journal of Hyperthermia has published the preliminary results of a phase II clinical study involving 144 patients with locally advanced prostate cancer. In this study BSD Medical's BSD-2000 hyperthermia system was used to deliver local hyperthermia combined with conformal radiation therapy and androgen suppression therapy in the treatment of prostate cancer. Hyperthermia combined with radiation and androgen therapy demonstrated results in survival similar to treatments using higher radiation doses, with no significant side effects associated with either hyperthermia or radiation therapy. The report is entitled "Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study" (see Int.
NRI creates mice resistant to cancer
An Indian-origin researcher at the University of Kentucky has led a team to create mice that are resistant to aggressive types of cancer. The might of the mouse comes from a tumour-suppressor gene in the prostate called Par-4, discovered by Vivek Rangnekar, professor of radiation medicine at the UK College of Medicine, who had completed his doctoral studies at the University of Bombay. The researchers discovered that the Par-4 gene kills cancer cells, but not normal cells. “The implications for humans could be that through bone marrow transplantation, the Par-4 molecule could potentially be used to fight cancer cells in patients without the toxic and damaging side effects of chemotherapy and radiation therapy,"' said the University's media statement announcing the breakthrough.
The war on cancer (LAT-WP/ By Devra Davis)
We've been fighting the war on cancer for almost four decades now, since President Richard M Nixon officially launched it in 1971. It's time to admit that our efforts have often targeted the wrong enemies and used the wrong weapons.
Throughout the industrial world, the war on cancer remains focused on commercially fueled efforts to develop drugs and technologies that can find and treat the disease to the tune of more than $100 bn a year in the United States alone. Meanwhile, the struggle basically ignores most of the things known to cause cancer, such as tobacco, radiation, sunlight, benzene, asbestos, solvents, and some drugs and hormones. Even now, modern cancer-causing agents such as gasoline exhaust, pesticides and other air pollutants are simply deemed the inevitable price of progress.
|
